Provided by Tiger Trade Technology Pte. Ltd.

ETF & Stock Investment

2,075.69
+17.030.83%
Number of Gainers:618
Number of Losers:389
Number of Flat:17
PE:- -
High:2,083.23
Open:2,058.90
Low:2,058.90
Close:2,058.66
Volume:6.00B
Turnover:741.53B
Market Cap:96.63T
Float Cap:90.45T

Loading ...

Truist Financial Price Target Cut to $54.00/Share from $56.00 by Evercore ISI Group

Dow Jones
·
Oct 01

Argan Lifts FY 2026 Rental Income Outlook to at Least €222 Million

Reuters
·
Oct 01

Nexity Reports 56,129,724 Issued Shares, 55,596,367 Net Voting Rights as of Sept. 30, 2026

Reuters
·
Oct 01

Coface Reports 150,179,792 Shares Outstanding, 149,512,977 Real Voting Rights as of Sept. 30, 2026

Reuters
·
Oct 01

Transgene to Attend Investor Access Event with Institutional Investors

Reuters
·
Oct 01

Citigroup Crosses 3% Solvay Stake Threshold, Disclosure Shows

Reuters
·
Oct 01

Air France-KLM Reports 262,769,869 Issued Shares, 375,182,213 Total Voting Rights as of Sept. 30, 2026

Reuters
·
Oct 01

Bouygues Reports 388,438,129 Shares Outstanding as of Sept. 30, 2026

Reuters
·
Oct 01

Accenture Stock is Heading for Its Best Day Ever. AI Isn't the Threat Everyone Thought.

Dow Jones
·
Oct 01

Why Fair Isaac Stock is Surging After Its Worst Quarter on Record

Dow Jones
·
Oct 01

EIA Reports 64-Bcf Injection in Natural Gas Storage

Dow Jones
·
Oct 01

Foghorn Stock Craters as Lilly Scraps Cancer Deal, Forcing Nearly Half of Staff Layoffs

Dow Jones
·
Oct 01

Experts Including Dalio Advise on How to Protect Wealth: 'We Are in a Bubble'

Deep News
·
Oct 01

Update: Market Chatter: Vale Eyes China Bond Debut to Diversify Funding Sources

MT Newswires Live
·
Oct 01

Top Midday Stories: Micron Shares Fall Despite Strong Earnings, Guidance; Broadcom to Lend Anthropic $42 Billion for Infrastructure Spending

MT Newswires Live
·
Oct 01

Synchrony Financial Price Target Cut to $80.00/Share from $86.00 by Evercore ISI Group

Dow Jones
·
Oct 01

Workday announces launch of operations in United Arab Emirates

TIPRANKS
·
Oct 01

Regeneron says COURAGE trial confirms trevogrumab prevents muscle loss

TIPRANKS
·
Oct 01

Datadog put volume heavy and directionally bearish

TIPRANKS
·
Oct 01

Regeneron Pharmaceuticals, - 9-Month Median Duration of Response Observed at 800 Mg Ubamatamab Dose

THOMSON REUTERS
·
Oct 01